---
action_items: []
artifact_hash: ddaa271d7e0fbb27fbcd4938db65359584d66295ab61c06b731a33033d49412f
artifact_path: projects/PROJ-305-statistical-analysis-of-publicly-availab/specs/001-statistical-analysis-of-publicly-availab/spec.md
backend: dartmouth
feedback: "The spec is largely coherent, but several claims do not survive contact\
  \ with the actual structure of the VAERS data, and one requirement is malformed.\
  \ First, User Story 2 states the comparison is 'vaccines to non-vaccines' \u2014\
  \ this is impossible in VAERS, which contains only reports following vaccination;\
  \ the actual comparison, as the rest of the spec correctly states, is COVID-19 vaccines\
  \ versus other vaccines. The wording should be corrected before it propagates into\
  \ the contingency-table defini"
github_authenticated: false
model_name: openai.gpt-oss-120b
prompt_version: 1.0.0
reviewed_at: '2026-10-18T20:05:57.331777Z'
reviewer_kind: llm
reviewer_name: alan-turing-simulated
score: 0.0
verdict: minor_revision
---

The spec is largely coherent, but several claims do not survive contact with the actual structure of the VAERS data, and one requirement is malformed. First, User Story 2 states the comparison is 'vaccines to non-vaccines' — this is impossible in VAERS, which contains only reports following vaccination; the actual comparison, as the rest of the spec correctly states, is COVID-19 vaccines versus other vaccines. The wording should be corrected before it propagates into the contingency-table definitions. Second, the Assumptions section asserts the dataset lacks VACCINATION_DATE 'for the vast majority of records'; VAERS public files include a VAX_DATE field that is populated for a large share of reports, so the entire 'Reporting Time only' design in FR-004 rests on an unverified empirical claim — the proportion of populated VAX_DATE should be measured in the P1 pipeline before the limitation is baked in. Third, and most substantively: VAERS data is distributed with one row per vaccine per report (the VAERSVAX file), so a single report listing both a COVID-19 vaccine and, say, an influenza vaccine will appear in both groups once records are classified by VAX_TYPE. Nothing in the spec addresses deduplication or the assignment rule for multi-vaccine reports, yet the 2x2 contingency tables count reports; without a rule (e.g., assign each VAERS_ID to exactly one group, or restrict to single-vaccine reports), both cells of the table are contaminated and the ROR/PRR/IC values are not well defined. Fourth, SC-005 is malformed: it reads '[deferred] of reported signals MUST satisfy...' with the proportion missing, so it is not a measurable criterion. Fifth, FR-002 requires an Information Component with a 95% confidence interval, but the IC is conventionally a Bayesian shrinkage statistic whose interval requires a specified prior (the gamma-Poisson model used by WHO-UMC); the spec gives no method, so the acceptance scenario's demand for 'finite, non-NaN, non-Infinity' numbers does not pin down what computation is to be verified. Finally, the assumption that MedDRA-to-SOC aggregation needs no curation is optimistic — VAERS symptom files carry Preferred Terms, and SOC grouping via MedDRA hierarchy requires either a licensed MedDRA copy or a mapping table; the spec should state which is used.

---

> *Note: this contribution was authored by **Alan Turing (simulated)** — a simulated AI persona shaped from the public-record writings of Alan Turing, running on `gpt-oss-120b` via Dartmouth Chat. It is not the actual Alan Turing.*
